Evidence map›Paper›PMID 40599105›Full record

ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025

In vivo and ex vivo sonographic evaluation of tumor margins during micrographic-controlled surgery: a promising new tool in dermato-oncology?

Diana Crisan, Ximena Wortsman, Fernando Alfageme, Karin Scharffetter-Kochanek, Maria Crisan, Lukas Bernhard, Evelyne Tarnowietzki, Lars Alexander Schneider, Monika-H Schmid-Wendtner

Abstract read
In one paragraph

Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. In vivo and ex vivo sonographic evaluation of tumor margins during micrographic-controlled surgery: a promising new tool in dermato-oncology?Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Diana CrisanClinic of Dermatology and Allergology, University Clinic Ulm, Ulm, Germany.ORCID 0000-0002-7479-5454
Ximena WortsmanDepartment of Dermatology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Fernando AlfagemeDermatology, Hospital Universitario Puerta De Hierro Majadahonda, Madrid, Spain.
Karin Scharffetter-KochanekClinic of Dermatology and Allergology, University Clinic Ulm, Ulm, Germany.
Maria CrisanDermatology, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
Lukas BernhardClinic of Dermatology and Allergology, University Clinic Ulm, Ulm, Germany.
Evelyne TarnowietzkiClinic of Dermatology and Allergology, University Clinic Ulm, Ulm, Germany.
Lars Alexander SchneiderClinic of Dermatology and Allergology, University Clinic Ulm, Ulm, Germany.
Monika-H Schmid-WendtnerInterdisciplinary Oncological Center, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe current research examined the In vivo and ex vivo use of high-frequency ultrasound (HFUS) during micrographic-controlled surgery (MCS) of non-melanoma skin cancer (NMSC) of the head-and-face area, particularly the perioperative surgical margin assessment for potential reduction in surgical steps and patients' hospitalization time. PATIENTS AND

methodsPre-operative in vivo and ex vivo sonographies of 136 NMSCs from 111 patients were evaluated retrospectively for tumor margin assessment during MCS by an experienced dermatosurgeon, while the specimens were independently assessed by a histopathologist.

resultsOur ex-vivo tumor margin assessment showed a specificity of >98% for squamous cell and basal cell carcinoma, with only five false-negative and two false-positive results, when compared to histopathology. HFUS correctly identified tumor-free margins in 89% of investigated lesions after first resection, as well as eight incomplete excisions (6%) in which a re-excision was performed and tumor residues were detected histologically. Overall, HFUS showed a very high accuracy in detecting both cancer-free margins and remaining tumor residues.

conclusionsHFUS is a highly accurate method for rapidly assessing tumor margins during MCS of NMSC of highly esthetic areas, having the potential to significantly reduce surgical steps and hospitalization time in dermatosurgical patients, improving the quality of healthcare.

Indexed as

Basal Cell CarcinomaCarcinoma, Squamous CellMargins of ExcisionMohs SurgerySkin NeoplasmsSurgery, Computer-AssistedAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedReproducibility of ResultsRetrospective StudiesSensitivity and Specificitydermatosurgeryimagingmicrographic controlled surgerynon‐melanoma skin cancerskin cancerultrasound

Identifiers

PMID40599105
PMCPMC12548316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.